Zenotech Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 683231, "name": "Zenotech Lab.", "stock_name": "Zenotech Lab.", "full_name": "Zenotech Laboratories Ltd", "name_url": "stocks-analysis/zenotech-lab", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "44.89", "chg": 0.61, "chgp": "1.38%", "dir": 1, "prev_price": "44.28", "mcapval": "270.00 Cr", "mcap": "Micro Cap", "scripcode": 532039, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE486F01012", "curr_date": "Aug 07, 03:30 PM", "curr_time": "03:46 AM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "757 ", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zenotech-lab-683231-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Zenotech Laboratories Gains 0.56%: 3 Key Factors Driving the Week’s Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-gains-056-3-key-factors-driving-the-weeks-move-4131784", "imagepath": "", "date": "2026-08-01 16:06:16", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Stock opens week with a 1.83% gain to Rs.45.10</p>\n <p><strong>28 Jul:</strong> Q1 FY27 results reveal deepening losses, stock falls 2.06%</p>\n <p><strong>30 Jul:</strong> Quality grade downgraded to average; Mojo rating cut to Strong Sell</p>\n <p><strong>31 Jul:</strong> Week closes at Rs.44.54, up 0.20% on the day but below week open</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.44.29</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div..." }, { "title": "Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amid-deteriorating-fundamentals-4128047", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_mojoScore_4128047.png", "date": "2026-07-30 08:13:57", "description": "Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 29 July 2026, reflecting deteriorating fundamentals across quality, valuation, financial trends, and technical indicators. The pharmaceutical company’s weakening operating performance, expensive valuation metrics, and persistent underperformance against benchmarks have prompted a reassessment of its outlook by analysts." }, { "title": "Zenotech Laboratories Ltd Quality Grade Downgrade: A Detailed Fundamental Analysis", "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-ltd-quality-grade-downgrade-a-detailed-fundamental-analysis-4127724", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_qualitydot_4127724.png", "date": "2026-07-30 08:00:06", "description": "Zenotech Laboratories Ltd has recently seen its quality grade downgraded from good to average, reflecting a shift in key business fundamentals. This article examines the underlying factors behind this change, analysing profitability metrics, debt levels, and operational efficiency to provide investors with a comprehensive view of the company’s evolving financial health." }, { "title": "Zenotech Laboratories Q1 FY27: Losses Deepen Amid Margin Collapse", "link": "https://www.marketsmojo.com/news/result-analysis/zenotech-laboratories-q1-fy27-losses-deepen-amid-margin-collapse-4124691", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_quaterlyResult_4124691.png", "date": "2026-07-28 20:01:32", "description": "Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company with a market capitalisation of ₹280.00 crores, reported a troubling quarter ended June 2026, posting a net loss of ₹0.46 crores compared to a profit of ₹0.99 crores in the corresponding quarter last year. The stock has reacted negatively to the results, trading at ₹44.17 as of July 28, 2026, down 2.06% on the day and reflecting broader concerns about the company's deteriorating operational performance and profitability metrics." }, { "title": "Zenotech Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-4117530", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_mojoScore_4117530.png", "date": "2026-07-23 10:11:14", "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "When is the next results date for Zenotech Laboratories Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-zenotech-laboratories-ltd-4102788", "imagepath": "", "date": "2026-07-14 23:16:36", "description": "The next results date for Zenotech Laboratories Ltd is scheduled for 28 July 2026...." }, { "title": "Zenotech Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-4097233", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ZenotechLaborat_mojoScore_4097233.png", "date": "2026-07-12 10:10:37", "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 July 2026, providing investors with the most up-to-date view of the company’s performance and outlook." }, { "title": "Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-4078229", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZenotechLaborat_mojoScore_4078229.png", "date": "2026-06-30 08:39:39", "description": "Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 29 June 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing financial challenges and valuation concerns. The upgrade is primarily driven by improvements in technical indicators, while fundamental and financial metrics continue to weigh on the stock’s prospects." }, { "title": "Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-4069815", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZenotechLaborat_mojoScore_4069815.png", "date": "2026-06-24 08:20:03", "description": "Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 June 2026, reflecting deteriorating fundamentals and increasingly negative technical indicators. The pharmaceutical micro-cap’s recent financial results, valuation metrics, and technical trends collectively triggered this reassessment, signalling heightened caution for investors." } ], "total": 151, "sid": "683231", "stock_news_url": "https://www.marketsmojo.com/news/zenotech-laboratories-683231" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "29-Jul-2026", "details": "Publication of extract of Unaudited Financial Results for the quarter ended June 30 2026 in newspapers.", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. July 28 2026", "datetime": "28-Jul-2026", "details": "Outcome of the Board Meeting held today i.e. July 28 2026", "source": "BSE" }, { "caption": "Unaudited Financial Results For The Quarter Ended June 30 2026", "datetime": "28-Jul-2026", "details": "Submission of Unaudited Financial Results of the Company for the quarter ended June 30 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Zenotech Laboratories Ltd has announced <strong>17:22</strong> rights issue, ex-date: 01 Jun 17", "dt": "2017-06-01", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

27 Jul: Stock opens week with a 1.83% gain to Rs.45.10

28 Jul: Q1 FY27 results reveal deepening losses, stock falls 2.06%

30 Jul: Quality grade downgraded to average; Mojo rating cut to Strong Sell

31 Jul: Week closes at Rs.44.54, up 0.20% on the day but below week open

Week Open

Rs.44.29

Week CloseRead full news article

Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals

2026-07-30 08:13:57

Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 29 July 2026, reflecting deteriorating fundamentals across quality, valuation, financial trends, and technical indicators. The pharmaceutical company’s weakening operating performance, expensive valuation metrics, and persistent underperformance against benchmarks have prompted a reassessment of its outlook by analysts.

Read full news article

Zenotech Laboratories Ltd Quality Grade Downgrade: A Detailed Fundamental Analysis

2026-07-30 08:00:06

Zenotech Laboratories Ltd has recently seen its quality grade downgraded from good to average, reflecting a shift in key business fundamentals. This article examines the underlying factors behind this change, analysing profitability metrics, debt levels, and operational efficiency to provide investors with a comprehensive view of the company’s evolving financial health.

Read full news article

Zenotech Laboratories Q1 FY27: Losses Deepen Amid Margin Collapse

2026-07-28 20:01:32

Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company with a market capitalisation of ₹280.00 crores, reported a troubling quarter ended June 2026, posting a net loss of ₹0.46 crores compared to a profit of ₹0.99 crores in the corresponding quarter last year. The stock has reacted negatively to the results, trading at ₹44.17 as of July 28, 2026, down 2.06% on the day and reflecting broader concerns about the company's deteriorating operational performance and profitability metrics.

Read full news article

Zenotech Laboratories Ltd is Rated Sell

2026-07-23 10:11:14

Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

When is the next results date for Zenotech Laboratories Ltd?

2026-07-14 23:16:36

The next results date for Zenotech Laboratories Ltd is scheduled for 28 July 2026....

Read full news article

Zenotech Laboratories Ltd is Rated Sell

2026-07-12 10:10:37

Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 July 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Zenotech Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-06-30 08:39:39

Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 29 June 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing financial challenges and valuation concerns. The upgrade is primarily driven by improvements in technical indicators, while fundamental and financial metrics continue to weigh on the stock’s prospects.

Read full news article

Zenotech Laboratories Downgraded to Strong Sell Amid Deteriorating Fundamentals and Bearish Technicals

2026-06-24 08:20:03

Zenotech Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 23 June 2026, reflecting deteriorating fundamentals and increasingly negative technical indicators. The pharmaceutical micro-cap’s recent financial results, valuation metrics, and technical trends collectively triggered this reassessment, signalling heightened caution for investors.

Read full news article